Literature DB >> 7462703

Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh.

R I Glass, I Huq, A R Alim, M Yunus.   

Abstract

In December 1979, a Vibrio cholerae O1 resistant to tetracycline, ampicillin, kanamycin, streptomycin, and trimethoprim-sulfamethoxazole was obtained from a patient with cholera at the Matlab Hospital, Bangladesh. All 256 isolates of V. cholerae O1 stocked in the previous six months were tested for antibiotic sensitivity: 54 were resistant to tetracycline, and 44 of these were resistant to all five antibiotics. The clinical presentation and hospital course for 51 patients with resistant strains of V. cholerae O1 and 102 patients with sensitive strains were compared by their medical records. Patients with resistant strains were indistinguishable from controls by age, sex, or severity of symptoms at presentation. All were treated with tetracycline, and patients with the resistant strains purged longer (mean, 37 vs. 25 hr; P less than 0.01) and in greater volume (mean 4.3 vs. 2.3 liters; P less than 0.01) and their controls with cholera due to susceptible strains. A resistance plasmid was identified. Based on these results, antibiotic use in the areas with resistant vibrios must be reconsidered.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7462703     DOI: 10.1093/infdis/142.6.939

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Molecular analysis of toxigenic Vibrio cholerae O139 Bengal strains isolated in Bangladesh between 1993 and 1996: evidence for emergence of a new clone of the Bengal vibrios.

Authors:  S M Faruque; K M Ahmed; A K Siddique; K Zaman; A R Alim; M J Albert
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Emergence of a new clone of toxigenic Vibrio cholerae O1 biotype El Tor displacing V. cholerae O139 Bengal in Bangladesh.

Authors:  S M Faruque; K M Ahmed; A R Abdul Alim; F Qadri; A K Siddique; M J Albert
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Vibrio cholerae serogroup O1 in northeast Thailand.

Authors:  T Kuyyakanond; S Nakamura; W Manmontri; M Iwanaga
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

4.  Distribution and content of class 1 integrons in different Vibrio cholerae O-serotype strains isolated in Thailand.

Authors:  A Dalsgaard; A Forslund; O Serichantalergs; D Sandvang
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

5.  Emergence and evolution of Vibrio cholerae O139.

Authors:  Shah M Faruque; David A Sack; R Bradley Sack; Rita R Colwell; Yoshifumi Takeda; G Balakrish Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

6.  Vitek system antimicrobial susceptibility testing of O1, O139, and non-O1 Vibrio cholerae.

Authors:  C V Sciortino; J A Johnson; A Hamad
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

7.  Drug response and genetic properties of Vibrio cholerae associated with endemic cholera in north-eastern Thailand, 2003-2011.

Authors:  Chariya Chomvarin; Fatema-Tuz Johura; Shahnewaj B Mannan; Warin Jumroenjit; Boonnapa Kanoktippornchai; Waraluk Tangkanakul; Napaporn Tantisuwichwong; Sriwanna Huttayananont; Haruo Watanabe; Nur A Hasan; Anwar Huq; Alejandro Cravioto; Rita R Colwell; Munirul Alam
Journal:  J Med Microbiol       Date:  2013-01-14       Impact factor: 2.472

8.  Efficacy of a single dose of furazolidone for treatment of cholera in children.

Authors:  G H Rabbani; T Butler; M Shahrier; R Mazumdar; M R Islam
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 9.  Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae.

Authors:  S M Faruque; M J Albert; J J Mekalanos
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

10.  Emergence of multidrug-resistant strain of Vibrio cholerae O1 in Bangladesh and reversal of their susceptibility to tetracycline after two years.

Authors:  Abu S G Faruque; Khorshed Alam; Mohammad A Malek; Mohammed G Y Khan; Sabeena Ahmed; Debasish Saha; Wasif A Khan; Gopinath B Nair; Mohammed A Salam; Stephen P Luby; David A Sack
Journal:  J Health Popul Nutr       Date:  2007-06       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.